Tanja Potpara, EHRA 2022: NOAC patient journey: i.e. bridging, ACS/PCI, renal dysfunction and comedication
Dr Tanja Potpara (Belgrade University School of Medicine, Belgrade, Serbia) kindly discussed with us her presentation on the journey of patients on novel oral anticoagulants (NOACs), which was presented during a session on atrial fibrillation clinical cases with focus on rhythm control and anticoagulation at this years EHRA.
‘NOAC patient journey: i.e. bridging, ACS/PCI, renal dysfunction and comedication‘ was presented at EHRA 2022, 03-05 April, 2022.
- What did your presentation raise regarding the management of patients with atrial fibrillation after acute coronary syndrome and/or percutaneous coronary intervention? (0:21)
- What issues were raised in terms of dosage in renal dysfunction and the concurrent use of other medications? (7:07)
- What were the key take-home messages of the presentation? (9:05)
Disclosures: Tatjana Potpara has nothing to disclose in relation to this video
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of the annual EHRA Conference 2022.
Share this Video
Related Videos In Atrial Fibrillation
World Heart Rhythm Week: Considerations and challenges in arrhythmia
It’s World Heart Rhythm Week 2023! Learn about key considerations for managing and treating arrhythmias, ongoing research and the importance of seeking medical advice for syncope.
Bruce Wilkoff, EHRA 2023: The AdaptResponse trial, synchronized left ventricular pacing for heart failure with left bundle branch block
The AdaptResponse trial was designed to assess two methods of restoring resynchronization to the heart in patients with heart failure with left bundle branch block. In this touchCARDIO interview, we speak with Dr Bruce Wilkoff (Cleveland Clinic, Cleveland, OH, USA) to discuss the design of the AdaptResponse trial, the outcomes as well as the clinical […]
Bruce Wilkoff, EHRA 2023: An overview of cardiac resynchronization therapy for patients with heart failure
Cardiac resynchronization therapy is designed to restore the electrical activation in a more natural way in patients with heart failure. In this touchCARDIO interview, we speak with Dr Bruce Wilkoff (Cleveland Clinic, Cleveland, OH, USA) to discuss the treatment paradigm with focus on cardiac resynchronization therapy for patients with heart failure. Bruce Wilkoff presented an […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!